Related Experiment Video
Updated: Apr 28, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
8-60hIPP5(m)-induced G2/M cell cycle arrest involves activation of ATM/p53/p21(cip1/waf1) pathways and delayed cyclin
Qi-Yan Zeng1, Lin-Jie Zeng, Yu Huang
1Department of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning, China
Abstract:
Protein phosphatase 1 (PP1) is a major serine/threonine phosphatase that controls gene expression and cell cycle progression. The active mutant IPP5 (8-60hIPP5(m)), the latest member of the inhibitory molecules for PP1, has been shown to inhibit the growth of human cervix carcinoma cells (HeLa). In order to elucidate the underlying mechanisms, the present study assessed overexpression of 8-60hIPP5(m) in HeLa cells. Flow cytometric and biochemical analyses showed that overexpression of 8-60hIPP5(m) induced G2/M-phase arrest, which was accompanied by the upregulation of cyclin B1 and phosphorylation of G2/M-phase proteins ATM, p53, p21(cip1/waf1) and Cdc2, suggesting that 8-60hIPP5(m) induces G2/M arrest through activation of the ATM/p53/p21(cip1/waf1)/Cdc2/ cyclin B1 pathways. We further showed that overexpression of 8-60hIPP5(m) led to delayed nuclear translocation of cyclin B1. 8-60hIPP5(m) also could translocate to the nucleus in G2/M phase and interact with pp1α and Cdc2 as demonstrated by co-precipitation assay. Taken together, our data demonstrate a novel role for 8-60hIPP5(m) in regulation of cell cycle in HeLa cells, possibly contributing to the development of new therapeutic strategies for cervix carcinoma.
Insights
The active mutant 8-60hIPP5(m) inhibits human cervix carcinoma (HeLa) cell growth by inducing G2/M-phase arrest. This occurs through the ATM/p53/p21(cip1/waf1)/Cdc2/cyclin B1 pathway, revealing a novel cell cycle regulation role.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Protein phosphatase 1 (PP1) is crucial for gene expression and cell cycle control.
- The inhibitory molecule 8-60hIPP5(m) has demonstrated potential in inhibiting human cervix carcinoma (HeLa) cell growth.
Purpose of the Study:
- To elucidate the mechanisms by which 8-60hIPP5(m) inhibits HeLa cell growth.
- To investigate the role of 8-60hIPP5(m) in cell cycle regulation.
Main Methods:
- Overexpression of 8-60hIPP5(m) in HeLa cells.
- Flow cytometry and biochemical analyses.
- Co-precipitation assays to determine protein interactions.
Main Results:
- Overexpression of 8-60hIPP5(m) induced G2/M-phase arrest in HeLa cells.
- This arrest was linked to the upregulation of cyclin B1 and phosphorylation of ATM, p53, p21(cip1/waf1), and Cdc2.
- 8-60hIPP5(m) delayed nuclear translocation of cyclin B1 and interacted with pp1α and Cdc2 in the nucleus.
Conclusions:
- 8-60hIPP5(m) plays a novel role in regulating the cell cycle of HeLa cells.
- The findings suggest potential therapeutic strategies for cervix carcinoma targeting these pathways.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
08:37Use of the Pyrimidine Analog, 5-Iodo-2′-Deoxyuridine IdU with Cell Cycle Markers to Establish Cell Cycle Phases in a Mass Cytometry Platform
Published on: October 22, 2021
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Negative Regulator Molecules
Inhibition of Cdk Activity